| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 8 | 2024 | 660 | 1.630 |
Why?
|
| Cell Death | 5 | 2025 | 280 | 1.580 |
Why?
|
| Signal Transduction | 11 | 2024 | 3020 | 1.290 |
Why?
|
| Genomics | 3 | 2024 | 357 | 1.270 |
Why?
|
| Apoptosis | 6 | 2024 | 1066 | 1.120 |
Why?
|
| DNA Damage | 5 | 2024 | 285 | 1.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 520 | 0.930 |
Why?
|
| Cell Line, Tumor | 12 | 2024 | 1451 | 0.890 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 66 | 0.810 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 78 | 0.790 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 194 | 0.780 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 445 | 0.770 |
Why?
|
| Software | 1 | 2025 | 381 | 0.740 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 761 | 0.720 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2020 | 20 | 0.710 |
Why?
|
| Biological Assay | 1 | 2021 | 58 | 0.700 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 59 | 0.690 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2020 | 18 | 0.670 |
Why?
|
| Optical Imaging | 1 | 2021 | 71 | 0.660 |
Why?
|
| Neoplasms | 5 | 2022 | 1350 | 0.620 |
Why?
|
| ErbB Receptors | 4 | 2020 | 114 | 0.600 |
Why?
|
| Stromal Cells | 1 | 2018 | 67 | 0.590 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 262 | 0.520 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1193 | 0.520 |
Why?
|
| Fibroblasts | 1 | 2018 | 392 | 0.520 |
Why?
|
| Systems Biology | 2 | 2015 | 33 | 0.500 |
Why?
|
| Interferon-beta | 1 | 2015 | 80 | 0.460 |
Why?
|
| Interferon-alpha | 1 | 2015 | 102 | 0.450 |
Why?
|
| Protein Binding | 2 | 2016 | 1601 | 0.450 |
Why?
|
| Phosphorylation | 2 | 2016 | 937 | 0.450 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2024 | 442 | 0.440 |
Why?
|
| Heme | 1 | 2014 | 29 | 0.440 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2024 | 564 | 0.420 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 225 | 0.420 |
Why?
|
| Drug Synergism | 3 | 2024 | 142 | 0.410 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 108 | 0.410 |
Why?
|
| Humans | 26 | 2025 | 62653 | 0.390 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 463 | 0.350 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 152 | 0.320 |
Why?
|
| Kinetics | 2 | 2021 | 764 | 0.300 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 769 | 0.290 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 82 | 0.280 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 60 | 0.280 |
Why?
|
| Models, Theoretical | 3 | 2019 | 271 | 0.270 |
Why?
|
| Transcription Factors | 3 | 2024 | 1508 | 0.260 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 68 | 0.240 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 431 | 0.240 |
Why?
|
| Cell Proliferation | 5 | 2020 | 981 | 0.230 |
Why?
|
| Calcineurin | 1 | 2024 | 47 | 0.220 |
Why?
|
| Stress, Physiological | 2 | 2024 | 193 | 0.220 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 78 | 0.210 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 128 | 0.210 |
Why?
|
| Spheniscidae | 1 | 2022 | 1 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 202 | 0.200 |
Why?
|
| Ubiquitination | 2 | 2016 | 111 | 0.200 |
Why?
|
| Mitochondria | 2 | 2024 | 366 | 0.200 |
Why?
|
| Conservation of Natural Resources | 1 | 2022 | 39 | 0.190 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 48 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 303 | 0.190 |
Why?
|
| Hydrogels | 2 | 2021 | 114 | 0.180 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2019 | 57 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 294 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2021 | 181 | 0.170 |
Why?
|
| Drug Antagonism | 1 | 2020 | 9 | 0.170 |
Why?
|
| Intelligence | 1 | 2020 | 55 | 0.170 |
Why?
|
| Models, Neurological | 1 | 2020 | 80 | 0.170 |
Why?
|
| Beclin-1 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Benchmarking | 1 | 2020 | 132 | 0.160 |
Why?
|
| Bioprinting | 1 | 2019 | 1 | 0.160 |
Why?
|
| Cell Line | 2 | 2021 | 2038 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2016 | 125 | 0.160 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.150 |
Why?
|
| Osteogenesis | 2 | 2019 | 146 | 0.150 |
Why?
|
| Endosomes | 1 | 2019 | 178 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2018 | 97 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2019 | 219 | 0.150 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2018 | 15 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 861 | 0.140 |
Why?
|
| Quinolones | 1 | 2018 | 29 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2018 | 31 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 86 | 0.140 |
Why?
|
| Journal Impact Factor | 1 | 2018 | 26 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2018 | 78 | 0.140 |
Why?
|
| Oligodendroglia | 1 | 2017 | 36 | 0.140 |
Why?
|
| Myelin Sheath | 1 | 2017 | 37 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2019 | 142 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2018 | 135 | 0.140 |
Why?
|
| Nerve Regeneration | 1 | 2017 | 36 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 46 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2018 | 119 | 0.140 |
Why?
|
| Animals | 8 | 2024 | 20579 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2019 | 1346 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 49 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 187 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2016 | 31 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 162 | 0.130 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Disease Management | 1 | 2018 | 234 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 59 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 151 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 151 | 0.120 |
Why?
|
| Protein Domains | 1 | 2016 | 148 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2024 | 129 | 0.120 |
Why?
|
| Female | 6 | 2020 | 32478 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2014 | 8 | 0.110 |
Why?
|
| Biotransformation | 1 | 2014 | 23 | 0.110 |
Why?
|
| Lignans | 1 | 2014 | 15 | 0.110 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 20 | 0.110 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 32 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 51 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 77 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 62 | 0.110 |
Why?
|
| Drug Resistance, Multiple | 1 | 2014 | 33 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 316 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2016 | 493 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2014 | 100 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2018 | 363 | 0.100 |
Why?
|
| Proteomics | 1 | 2015 | 284 | 0.100 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 431 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2019 | 517 | 0.100 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2014 | 179 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2012 | 64 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 1550 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 72 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 658 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 87 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 232 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2014 | 774 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 139 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 643 | 0.090 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2024 | 20 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 256 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2024 | 392 | 0.080 |
Why?
|
| Models, Biological | 2 | 2012 | 1180 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2014 | 1143 | 0.080 |
Why?
|
| Proteins | 1 | 2015 | 749 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 9 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1611 | 0.080 |
Why?
|
| Vacuoles | 1 | 2009 | 26 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 148 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 773 | 0.070 |
Why?
|
| Chromatin | 1 | 2013 | 618 | 0.070 |
Why?
|
| Pheromones | 1 | 2008 | 22 | 0.070 |
Why?
|
| Mice | 5 | 2024 | 10802 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2019 | 618 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2004 | 7 | 0.060 |
Why?
|
| Calcium Chloride | 1 | 2024 | 18 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 98 | 0.060 |
Why?
|
| Cell Survival | 2 | 2018 | 573 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 48 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 129 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1184 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 171 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 224 | 0.050 |
Why?
|
| Antarctic Regions | 1 | 2022 | 3 | 0.050 |
Why?
|
| Introduced Species | 1 | 2022 | 2 | 0.050 |
Why?
|
| Climate Change | 1 | 2022 | 24 | 0.050 |
Why?
|
| Biodiversity | 1 | 2022 | 38 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 55 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2022 | 112 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 337 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 168 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3740 | 0.040 |
Why?
|
| Insulin | 1 | 2024 | 687 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 33 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 7 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 139 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 207 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 348 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 39 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 85 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2019 | 142 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 149 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 82 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 189 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 455 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 336 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 519 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 521 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 51 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 432 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1159 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 852 | 0.030 |
Why?
|
| Quinazolines | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, Death Domain | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 37 | 0.030 |
Why?
|
| Liposomes | 1 | 2014 | 106 | 0.030 |
Why?
|
| Stents | 1 | 2018 | 486 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 99 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 70 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 700 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 15 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 8 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 121 | 0.030 |
Why?
|
| Lysine | 1 | 2013 | 82 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 318 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 199 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 893 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 21 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 155 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 246 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 454 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 396 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3258 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 482 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 352 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6528 | 0.020 |
Why?
|
| Protein Transport | 1 | 2004 | 402 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2573 | 0.010 |
Why?
|
| Male | 1 | 2017 | 29472 | 0.010 |
Why?
|